Misplaced Pages

COVID-19 vaccination in Sri Lanka

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka
A Sri Lankan woman is vaccinated in 2021 as part of the COVAX initiative
Date29 January 2021 (2021-01-29) – present
LocationSri Lanka
CauseCOVID-19 pandemic in Sri Lanka
Organized byGovernment of Sri Lanka
Outcome
  • 56.4% of the Sri Lankan population has received at least one dose (as of 28 August 2021)
  • 31.5% of Sri Lankan population has received both doses (as of 28 August 2021)
Part of a series on the
COVID-19 pandemic
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Timeline
2019
2020
2021
2022
2023
Locations
By country and territory
By conveyance
International response
National responses
Medical response
Vaccines
Current vaccines
Variants
Variants of concern
Other variants
Economic impact and recession
By country
By sport
Impacts
Long COVID
Society
Politics
virus icon COVID-19 portal

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

Background

The Government of Sri Lanka commenced its COVID-19 vaccination program under the COVAX facility with first batch of Oxford–AstraZeneca vaccines arrive in Sri Lanka on 28 January 2021 from the Serum Institute of India. (SII).

Shortages

By April, with a surge in COVID cases in a third wave of infections, Sri Lanka faced a severe shortage of the Astra-Zeneca vaccine due to an export ban by India. This left majority of the 3.5% of the population that was given the first dose without access to the second. Sri Lanka faced an shortage of Sputnik V vaccine due to a spike of cases in Russia resulting in the manufacturer Gamaleya Research Institute of Epidemiology and Microbiology, focusing on meeting local demand.

Other vaccine supplies

In March 2021, the Sinopharm BIBP vaccine was approved emergency use. In May, the country ordered 14 million doses on top of 1.1 million doses previously donated. By July, Sri Lanka had received 10.7 million doses of the vaccine. In June, local studies in the country showed vaccination with the Sinopharm BIBP vaccine generated seroconversion and antibody responses in individuals to Delta and Beta variants similar to antibody levels seen following a natural infection

Phase three

With vaccination of persons above 30 years reaching completion, vaccination of those between 18 and 30 years who did not fall under special categories were started in early September 2021.

Proposed vaccine production

On 27 May State Minister for Pharmaceuticals Channa Jayasumana told reporters Sri Lanka was considering co-production of CoronaVac. It was not clarified if it would handle full production or a fill and finish plant.

Vaccination programme

Vaccines used

Currently, the vaccines approved by government of Sri Lanka for emergency use are:

Vaccine Approval Deployment
Oxford–AstraZeneca Yes Yes
Sinopharm BIBP Yes Yes
Sputnik V Yes Yes
Pfizer–BioNTech Yes Yes
Moderna Yes Yes
Sinovac Yes No

Vaccine distribution

Vaccine types were deployed on a geographical and group basis:

Special groups
  • Medical professionals and front line workers: Oxford–AstraZeneca
  • Students travelling overseas for studies: Pfizer–BioNTech
  • Migrant workers travelling overseas for work: Pfizer–BioNTech
  • Fishermen in Mannar: Pfizer–BioNTech
Geographical
  • Western province: Oxford–AstraZeneca, Sinopharm BIBP
  • Central province: Sputnik V, Moderna
  • Southern province: Oxford–AstraZeneca, Sinopharm BIBP
  • North Western province: Oxford–AstraZeneca, Sinopharm BIBP
  • Northern province: Sinopharm BIBP
  • Eastern province: Sinopharm BIBP
  • Sabaragamuwa province: Sinopharm BIBP
  • Uva province: Sinopharm BIBP
  • North central province: Sinopharm BIBP

Vaccine on order

Vaccine Type (technology) Doses ordered Manufacturer Remarks
Oxford–AstraZeneca Viral vector 8,400,000 India Serum Institute -
Sputnik V Viral vector 13,000,000 Russia R-Pharm -
Pfizer–BioNTech RNA 14,900,000 United States Pfizer -
Sinopharm BIBP Inactivated virus 23,000,000 China Sinopharm -

References

  1. ^ "Sri Lanka had little choice except China's Sinopharm: Weeratunga". EconomyNext. 29 July 2021. Archived from the original on 29 July 2021. Retrieved 29 July 2021.
  2. "U.S. donates over 1.5 million Moderna COVID-19 vaccines to Sri Lanka". usembassy.gov. US Embassy in Sri Lanka. 16 July 2021. Archived from the original on 30 July 2021. Retrieved 30 July 2021.
  3. ^ "First batch of COVID-19 vaccines from the COVAX Facility arrive in Sri Lanka". who.int. Archived from the original on 3 June 2021. Retrieved 2 June 2021.
  4. "Sri Lanka's COVID-19 Response: Saving Lives Today, Preparing for Tomorrow". World Bank. Archived from the original on 23 September 2023. Retrieved 10 February 2022.
  5. "The Latest: Sri Lanka looks to ease shortage with Sputnik V". independent.co.uk. Archived from the original on 2 June 2021. Retrieved 2 June 2021.
  6. "Sputnik V vaccine supply hindered due to spike in Covid cases in Russia". Daily Mirror. Archived from the original on 30 July 2021. Retrieved 30 July 2021.
  7. "NMRA approves sinopharm vaccine for emergency use". Colombo Gazette. 19 March 2021. Retrieved 20 March 2021.
  8. ^ "The Latest: Sri Lanka gets 2nd vaccine donation from China". ABC News. Archived from the original on 25 May 2021. Retrieved 28 May 2021.
  9. "Tests in Sri Lanka find Sinopharm vaccine very effective". Colombo Gazette. 20 July 2021. Archived from the original on 20 July 2021. Retrieved 21 July 2021.
  10. Jeewandara, Chandima; Aberathna, Inoka Sepali; Pushpakumara, Pradeep Dharshana; Kamaladasa, Achala; Guruge, Dinuka; Jayathilaka, Deshni; Gunesekara, Banuri; Tanussiya, Shyrar; Kuruppu, Heshan; Ranasinghe, Thushali; Dayarathne, Shashika (19 July 2021). "Antibody and T cell responses to Sinopharm/BBIBP-CorV in naive and previously infected individuals in Sri Lanka". medRxiv 10.1101/2021.07.15.21260621v1.
  11. ^ "Govt. aims to complete vaccinating all above 18 by September end". Adaderana. Archived from the original on 19 August 2021. Retrieved 19 August 2021.
  12. "Sri Lanka to co-produce Sinovac vaccines: Minister". EconomyNext. 27 May 2021. Archived from the original on 11 June 2021. Retrieved 11 June 2021.
  13. "Sri Lanka begins administering Sinopharm vaccines". xinhuanet. Archived from the original on 6 October 2021. Retrieved 2 June 2021.
  14. "Sri Lanka rolls out Russia's Sputnik V vaccine". The Hindu. Archived from the original on 11 October 2021. Retrieved 2 June 2021.
  15. "Sri Lanka to purchase 900,000 doses of Pfizer-BionTech COVID-19 vaccine in July". economynext.com. Archived from the original on 3 June 2021. Retrieved 2 June 2021.
  16. "Sri Lanka eyes 3mn Sinopharm Covid-19 doses to ramp up Coronavirus vaccination drive". economynext.com. Archived from the original on 2 June 2021. Retrieved 2 June 2021.
COVID-19 vaccination in Asia
Sovereign states
States with
limited recognition
Dependencies and
other territories
COVID-19 pandemic
Timeline
Pre-pandemic
2020
2021
2022
2023
Locations
Africa
Northern
Eastern
Southern
Central
Western
Asia
Central/North
East
Mainland China
South
India
By location
Southeast
Malaysia
Philippines
West
Europe
United Kingdom
By location
Eastern
Western Balkans
European Union
EFTA countries
Microstates
North
America
Atlantic
Canada
Caribbean
Countries
British Overseas Territories
Caribbean Netherlands
French West Indies
US insular areas
Central America
United States
responses
By location
Oceania
Australia
New Zealand
South
America
Others
Impact
Culture and
entertainment
Arts and
cultural heritage
Education
By country
Sports
By country
By sport
Society
and rights
Social impact
Labor
Human rights
Legal
Minority
Religion
Economic
By country
By industry
Supply and trade
Financial markets
Information
Misinformation
Politics
Political impact
Protests
International relations
Language
Others
Health issues
Medical topics
Testing and
epidemiology
Apps
Prevention
Vaccines
Topics
Authorized
DNA
Inactivated
mRNA
Subunit
Viral vector
Virus-like particles
In trials
Attenuated
DNA
Inactivated
RNA
Subunit
Viral vector
Virus-like particles
Deployment
by location
Africa
Asia
Europe
North America
Oceania
South America
Others
Treatment
Monoclonal antibodies
Small molecule antivirals
Variants
Specific
General
Institutions
Hospitals and
medical clinics
Mainland China
Others
Organizations
Health
institutes
Pandemic
institutes
Relief funds
People
Medical
professionals
Researchers
Officials
WHO
By location
Others
List of deaths due to COVID-19
Data (templates)
Global
Africa
Americas
Asia
Europe
Oceania
Others
Categories:
COVID-19 vaccination in Sri Lanka Add topic